These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

793 related articles for article (PubMed ID: 16238585)

  • 1. Role of cysteinyl leukotrienes in airway inflammation and responsiveness following RSV infection in BALB/c mice.
    Fullmer JJ; Khan AM; Elidemir O; Chiappetta C; Stark JM; Colasurdo GN
    Pediatr Allergy Immunol; 2005 Nov; 16(7):593-601. PubMed ID: 16238585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Respiratory syncytial virus-induced airway hyperresponsiveness is independent of IL-13 compared with that induced by allergen.
    Park JW; Taube C; Yang ES; Joetham A; Balhorn A; Takeda K; Miyahara N; Dakhama A; Donaldson DD; Gelfand EW
    J Allergy Clin Immunol; 2003 Dec; 112(6):1078-87. PubMed ID: 14657862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune and functional role of nitric oxide in a mouse model of respiratory syncytial virus infection.
    Stark JM; Khan AM; Chiappetta CL; Xue H; Alcorn JL; Colasurdo GN
    J Infect Dis; 2005 Feb; 191(3):387-95. PubMed ID: 15633098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness.
    Schwarze J; Cieslewicz G; Joetham A; Ikemura T; Hamelmann E; Gelfand EW
    J Immunol; 1999 Apr; 162(7):4207-11. PubMed ID: 10201948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 4 phosphodiesterase inhibitors attenuate respiratory syncytial virus-induced airway hyper-responsiveness and lung eosinophilia.
    Ikemura T; Schwarze J; Makela M; Kanehiro A; Joetham A; Ohmori K; Gelfand EW
    J Pharmacol Exp Ther; 2000 Aug; 294(2):701-6. PubMed ID: 10900250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study to elucidate the mechanism underlying the difference in airway hyperresponsiveness between two mouse strains.
    Fukunaga J; Abe M; Murai A; Akitake Y; Hosokawa M; Takahashi M
    Int Immunopharmacol; 2007 Dec; 7(14):1852-61. PubMed ID: 18039522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model.
    Wong WS; Zhu H; Liao W
    Eur J Pharmacol; 2007 Dec; 575(1-3):134-41. PubMed ID: 17689528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mepacrine alleviates airway hyperresponsiveness and airway inflammation in a mouse model of asthma.
    Ram A; Mabalirajan U; Singh SK; Singh VP; Ghosh B
    Int Immunopharmacol; 2008 Jun; 8(6):893-9. PubMed ID: 18442795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of primary and secondary low-grade respiratory syncytial virus infections in a murine model of asthma.
    Kondo Y; Matsuse H; Machida I; Kawano T; Saeki S; Tomari S; Obase Y; Fukushima C; Kohno S
    Clin Exp Allergy; 2004 Aug; 34(8):1307-13. PubMed ID: 15298574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of LTD(4)in allergic pulmonary inflammation in mice: modulation by cysLT(1)antagonist MK-571.
    Blain JF; Sirois P
    Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):361-8. PubMed ID: 10913229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfer of the enhancing effect of respiratory syncytial virus infection on subsequent allergic airway sensitization by T lymphocytes.
    Schwarze J; Mäkelä M; Cieslewicz G; Dakhama A; Lahn M; Ikemura T; Joetham A; Gelfand EW
    J Immunol; 1999 Nov; 163(10):5729-34. PubMed ID: 10553105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.
    Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J
    J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-5 and eosinophils are essential for the development of airway hyperresponsiveness following acute respiratory syncytial virus infection.
    Schwarze J; Cieslewicz G; Hamelmann E; Joetham A; Shultz LD; Lamers MC; Gelfand EW
    J Immunol; 1999 Mar; 162(5):2997-3004. PubMed ID: 10072551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune interaction between respiratory syncytial virus infection and allergen sensitization critically depends on timing of challenges.
    Peebles RS; Hashimoto K; Collins RD; Jarzecka K; Furlong J; Mitchell DB; Sheller JR; Graham BS
    J Infect Dis; 2001 Dec; 184(11):1374-9. PubMed ID: 11709778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus induces pneumonia, cytokine response, airway obstruction, and chronic inflammatory infiltrates associated with long-term airway hyperresponsiveness in mice.
    Jafri HS; Chavez-Bueno S; Mejias A; Gomez AM; Rios AM; Nassi SS; Yusuf M; Kapur P; Hardy RD; Hatfield J; Rogers BB; Krisher K; Ramilo O
    J Infect Dis; 2004 May; 189(10):1856-65. PubMed ID: 15122522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory syncytial virus infection does not increase allergen-induced type 2 cytokine production, yet increases airway hyperresponsiveness in mice.
    Peebles RS; Sheller JR; Collins RD; Jarzecka AK; Mitchell DB; Parker RA; Graham BS
    J Med Virol; 2001 Feb; 63(2):178-88. PubMed ID: 11170055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of CD8+ T lymphocytes attenuates respiratory syncytial virus-enhanced allergic inflammation.
    Jiang XB; Wang ZD; Zhu Y; Zhang XL; Cui XF; Yao K; Yin KS
    Respiration; 2009; 77(1):76-84. PubMed ID: 18818487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-Selectin is required for the development of airway hyperresponsiveness but not airway inflammation in a murine model of asthma.
    Fiscus LC; Van Herpen J; Steeber DA; Tedder TF; Tang ML
    J Allergy Clin Immunol; 2001 Jun; 107(6):1019-24. PubMed ID: 11398079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection.
    Kong X; Hellermann GR; Patton G; Kumar M; Behera A; Randall TS; Zhang J; Lockey RF; Mohapatra SS
    Virol J; 2005 Feb; 2():3. PubMed ID: 15701174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison study between the mechanisms of allergic asthma amelioration by a cysteinyl-leukotriene type 1 receptor antagonist montelukast and methylprednisolone.
    Murai A; Abe M; Hayashi Y; Sakata N; Katsuragi T; Tanaka K
    J Pharmacol Exp Ther; 2005 Feb; 312(2):432-40. PubMed ID: 15470084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.